Cui L - Search Results

1

Enhanced Efficacy against Drug-Resistant Tumors Enabled by Redox-Responsive Mesoporous-Silica-Nanoparticle-Supported Lipid Bilayers as Targeted Delivery Vehicles.

Yang S, Zhang B, Zhao X, Zhang M, Zhang M, Cui L, Zhang L. Yang S, et al. Among authors: cui l. Int J Mol Sci. 2024 May 20;25(10):5553. doi: 10.3390/ijms25105553. Int J Mol Sci. 2024. PMID: 38791591 Free PMC article.

2

Cell Type-Dependent Specificity and Anti-Inflammatory Effects of Charge-Reversible MSNs-COS-CMC for Targeted Drug Delivery in Cervical Carcinoma.

Cui L, Feng X, Liu W, Liu H, Qin Q, Wu S, He S, Pang X, Men D, Zhu C. Cui L, et al. Mol Pharm. 2020 Jun 1;17(6):1910-1921. doi: 10.1021/acs.molpharmaceut.0c00004. Epub 2020 Apr 6. Mol Pharm. 2020. PMID: 32223247

3

Chitosan oligosaccharide-functionalized nano-prodrug for cascade chemotherapy through oxidative stress amplification.

Cui L, Xu Q, Lou W, Wang Y, Xi X, Chen Y, Sun M, Wang Z, Zhang P, Yang S, Zhang L, Qu L. Cui L, et al. Int J Biol Macromol. 2024 May;268(Pt 2):131641. doi: 10.1016/j.ijbiomac.2024.131641. Epub 2024 Apr 18. Int J Biol Macromol. 2024. PMID: 38641277

4

Aversatile MOF as an electrochemical/fluorescence/colorimetric signal probe for the tri-modal detection of MMP-9 secretion in the extracellular matrix to identify the efficacy of chemotherapeutic drugs.

Wang Z, Guo L, Tian J, Han Y, Zhai D, Cui L, Zhang P, Zhang X, Yang S, Zhang L. Wang Z, et al. Among authors: cui l. Anal Chim Acta. 2024 Aug 1;1315:342798. doi: 10.1016/j.aca.2024.342798. Epub 2024 Jun 4. Anal Chim Acta. 2024. PMID: 38879217

5

Hybrid Liposome-MSN System with Co-Delivering Potential Effective Against Multidrug-Resistant Tumor Targets in Mice Model.

Yang Y, Yang S, Zhang B, Wang J, Meng D, Cui L, Zhang L. Yang Y, et al. Among authors: cui l. Int J Nanomedicine. 2024 Sep 2;19:8949-8970. doi: 10.2147/IJN.S472276. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39246424 Free PMC article.

6

Cell membrane camouflaged Cu-doped mesoporous polydopamine for combined CT/PTT/CDT synergistic treatment of breast cancer.

Meng D, Yang S, Ju L, Wang J, Yang Y, Zhang L, Cui L. Meng D, et al. Among authors: cui l. Biomed Pharmacother. 2024 Nov;180:117539. doi: 10.1016/j.biopha.2024.117539. Epub 2024 Oct 9. Biomed Pharmacother. 2024. PMID: 39383733 Free article.

7

Early Diagnosis of Tumorigenesis via Ratiometric Carbon Dots with Deep-Red Emissive Fluorescence Based on NAD⁺ Dependence.

Cui L, Lou W, Sun M, Wei X, Yang S, Zhang L, Qu L. Cui L, et al. Molecules. 2024 Nov 11;29(22):5308. doi: 10.3390/molecules29225308. Molecules. 2024. PMID: 39598697 Free PMC article.

8

Preparation of chitosan‑silicon dioxide/BCSG1‑siRNA nanoparticles to enhance therapeutic efficacy in breast cancer cells.

Cui L, Zheng R, Liu W, Shen P, Tang Y, Luo J, Zhang W, Jia G, Wang Y, Zhao S, Xie Q, Li Y. Cui L, et al. Mol Med Rep. 2018 Jan;17(1):436-441. doi: 10.3892/mmr.2017.7887. Epub 2017 Oct 26. Mol Med Rep. 2018. PMID: 29115613

9

pH-Triggered Charge-Reversal Mesoporous Silica Nanoparticles Stabilized by Chitosan Oligosaccharide/Carboxymethyl Chitosan Hybrids for Effective Intracellular Delivery of Doxorubicin.

Cui L, Liu W, Liu H, Qin Q, Wu S, He S, Pang X, Zhu C, Shen P. Cui L, et al. ACS Appl Bio Mater. 2019 May 20;2(5):1907-1919. doi: 10.1021/acsabm.8b00830. Epub 2019 May 6. ACS Appl Bio Mater. 2019. PMID: 35030680

10

Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis.

Cui L, Zhao S, Teng HL, Yang B, Liu Q, Qin A. Cui L, et al. NPJ Precis Oncol. 2025 Jan 17;9(1):19. doi: 10.1038/s41698-024-00794-5. NPJ Precis Oncol. 2025. PMID: 39825088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,046 results

Search Page

Filters